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This review discusses the commonly employed methods for viral immunodiagnosis, mentions
unusual or novel procedures, and briefly refers to the use of monoclonal antibody.
INTRODUCTION
The perception of the spectrum of viral disease has expanded markedly owing to a
recognition ofthe role ofviruses in such diverse states asjuvenile diarrhea, congenital
mental impairment, death after transplantation, cancer, and chronic neurological
dysfunction. The transmission of viral disease has been enormously facilitated by
widespread air travel which has placed even such exotic horrors as the lassa fever on
the doorstep ofpotentially any physician. Meanwhile, the isolation ofinterferons and
the prospect of effective chemotherapy have further accentuated the need for prompt
and effective viral diagnostic measures. Fortunately, this requirement has been
accompanied by the growth of an increasingly sophisticated methodology of immu-
noassay.
Immunodiagnostic assays can rapidly identify the virus in cell smears (e.g., buccal,
cervical) or body fluids (e.g., CSF, urine) as well as determine the class and
concentration ofantibody to a selected antigen (e.g., early or late) in any body fluid.
The assay of antigen is familiar for hepatitis. It may prove equally familiar for
cytomegalovirus, herpesvirus 2, and others with the development of effective
measures for the control ofthe viruses. The assays for humoral and cellular immunity
are becoming increasinglyvaluable as the significance ofthe various modalities ofthe
immune response is recognized for its diagnostic and prognostic implications. The
assays are also likely to become important for monitoring the efficacy ofvaccination
and chemotherapy.
The exploitation of immunoassay for viral diagnosis supplements the standard
procedures of culture, complement fixation, electron microscopy, etc., which are
frequently slower, less sensitive, or more expensive. The newer procedures offer
specialized alternatives to the dedicated viral laboratory but, even more important,
they bring viral immunodiagnosis within the reach of a competent hospital labora-
tory. The ambiance ofan immediate availability ofthe tests in a clinical milieu should
favor their effective utilization.
Consideration of viral immunodiagnosis can be undertaken under three headings:
the virus as an antigen, the immune response to the viral antigen, and the methods of
assay. This synopsis will deal principally with the last of the three topics.
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Viral Antigens
Virus associated
External antigens
Functional:
-for attachment
infectious
adventitious
-enzymatic
Structural:
glycoproteins
other substances
Internal antigens
Cell associated
Early antigens
(formed before viral replication)
Late antigens
(formed after replication has begun)
Immune complexes
Virus as an Antigen
Table 1 lists the types of viral antigen. Identification of an infecting virus in the
cells ofthe host, or in culture, generally depends on external antigens of the virus or
on cell-associated antigens. Immunodiagnostic identification requires the availability
of suitable, specific antisera. Subsequent characterization of the antigenic composi-
tion of a virus can utilize disrupted viruses orcells and employ internal antigens. The
presence of the antigens can be assayed by general methods, such as complement
fixation (CF), radioimmunoassay (RIA), or enzyme linked immunoassay (EIA), but
an initial identification of antigens in a mixture is often best accomplished by
precipitation techniques (for example, double immunodiffusion, immunoelectro-
phoresis, or crossed immunoelectrophoresis). External orcell-associated antigens are
generally detected by methods such as immunofluorescence (IF) or EIA. Functional
antigens responsible for viral attachment to cells are tested in neutralization assays,
while adventitious attachment is assayed by hemagglutination. Glycoproteins, in
addition to being identifiable by the various procedures used for structural antigens,
may also be detected by specific reactivity with lectins. Inhibition of a viral infection
by lectins has been described [1]. A systematic use of lectins for viral identification
has not been attempted but seems to offer interesting possibilities.
The identification of cell-associated antigen has been useful chiefly in the assay of
the appropriate antibodies. However, cell-associated antigens especially the early
ones, can be detected with appropriate antisera in tissue or cultured cells for quicker
identification of the virus.
Detection of immune complexes has become clinically significant [2], especially in
patients with nephritis, vasculitis, or autoimmune disorders. Identification of the
antigen in the complex assists in the differential diagnosis of the disorder. Further-
more, identification of the responsible virus permits a distinction to be drawn
betweendirect consequences ofan underlyingdisease (e.g., anautoimmune state) and
acomplicating viral infection. It also allows the detection ofviral infections which are
most likely to become complicated by sequelae caused by immune complexes.
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Immune Response in Viral Infection
The immune response in viral infection includes both a cellular and a humoral
component [3] but either, or both, may fail to occur in an immunodeficient or
immunosuppressed individual. Manifestation of immunity may be systemic and/or
local. Either of these manifestations can develop without the other.
Local immunity is characterized by an IgA antibody response which occurs
typically within one to two weeks, varies in duration, but does not manifest a recall
(secondary, booster, or memory) component. A variable amount of the antibody in
secretion is derived from serum. This fraction can be increased if there is local
bleeding, ulceration, or other cause for increased exudation. Clinical assessment of
antiviral, secretory antibody has received only limited attention, but may be
important for local recurrence or persistence of infection (e.g., in the respiratory [4],
and urogenital tracts [5]).
Cell-mediated immunity is a prominent feature of the host's response to the virus.
It was the first immune response to have been described, "a change produced in the
constitution [which] is not affected by time" [6]. Recently, it has been shown that the
ability of lymphocytes to respond to a viral infection depends on the recognition ofa
histocompatibility antigen [7] modified in the course of the infection, or co-present
on the cell surface with a closelyjuxtaposed, virally determined antigen. Quantifica-
tion of cell-mediated immunity is, however, subject to technical difficulties which
have prevented its routine exploitation. Nevertheless, in vitro tests can provide
substantial information about an individual's ability to respond to viral infection
[8,9]. Further development of these tests may assist in the clinical analysis ofvirally
induced, cell-associated antigens and be useful in the detection of recent or current
infection [10], or differentiation of an infectious syndrome (e.g., mumps meningitis
[11]). In vivo challenge (skin testing) with viral antigens is limited in usefulness. Its
primary role is in the detection of an individual's ability to respond to common viral
antigens as a measure ofthe retention ofa competent cell-mediated immune response
(delayed hypersensitivity) rather than as a diagnostic tool in infection [12].
An aspect of cellular immunity which may gain special prominence is the
measurement of virally induced lymphokines (e.g., migration inhibitory factor [13]
or interferon [14]). The measurement of interferon level in serum may be used either
to assess the response to infection or to monitor the persistence of the material
administered for therapy.
Humoral antibody can be used in two ways. Specific antibody can beemployed to
identify the virus recovered from an individual or present in tissue culture. Systemic
antibody can be assayed to determine the type and course of infection by the use of
viral antigen of known specificity.
The systemic antibody response can involve all classes of immunoglobulins [15].
Generally, an IgM response is observed within one to two weeks (e.g., with CMV,
EBV, measles, rubella, mumps) and an IgG response a fewdays later[16]. A maximal
1gM response is typically seen in three to six weeks, with subsequent decline in two to
three months, while an IgG response becomes maximal in four to twelve weeks and
persists for months or years before declining. Determination of the IgM response is
therefore more useful in primary or current infection [17,18] and that of IgG for the
assessment ofimmunity (e.g., to poliomyelitis) orepidemiological study, as well as in
acute infection. However, an IgM response may not be apparent, may be intermittent
or prolonged, or may occur later. It may recur with subsequent infection. Similarly,
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Features of Some Common Viral Infections
Typical Interval Before the Appearance of
Symptoms Antibody Immunodiagnostic
Infecting Agent (days) (weeks) Method(s)*
Adenovirus 4 2-3 CF, N
Cytomegalovirus 40 2-3 CF, IF
Enterovirus 9 1 N
Epstein-Barr Virus 35 1 HET, IF
Herpesvirus 6 <1-2 CF
Influenza 2 1-2 CF, HI
Measles 10 <1 HI, CF
Mumps 14 <1 CF
Rubella 17 1 HI, CF
*Abbreviations: CF = complement fixation
HI = hemagglutination inhibition
N = neutralization
HET = heterophile
IF = immunofluorescence
variation is encountered in the level and duration of the IgG response. These
differences are reflected in the results of tests which measure the antibody. Further-
more, some assays are more affected by IgM antibody [191(for example, passive or
indirect hemagglutination, or hemagglutination-inhibition), while others depend on
IgG (e.g., IgG-specific immunofluorescence), so that diverse results can be obtained.
The lapse of time between infection and the appearance ofmeasurable antibody also
varies with the virus (Table 2) and even the viral antigen: e.g., with EBV the antibody
to viral capsid antigen appears within days, to nuclear antigen after several weeks or
months, but to soluble antibody (by complement fixation) after months to years [20].
Systemic antibody of the IgA or IgD class [15] has undetermined biological
significance. Antibody of the IgE class [21] has also received little attention, possibly
because viral disease is generally unassociated with immediate hypersensitivity to the
virus, though allergy to vaccines can occur, especially to contaminants such as egg
protein.
Methodsfor Immunodiagnosis
The methods used for immunodiagnosis employ either labelled or unlabelled
reagents (Table 3). Application of the commonest methods is represented in Table 4.
An example of a novel approach to the use ofunlabelled reagents is calorimetry [22].
The results of the various methods are likely to differ owing to differences in their
sensitivity as well as the specificity, appearance, duration, and class of the measured
antibody.
Methods which use unlabelled materials depend on the expression (or inhibition of
the expression) of some measurable function: e.g., neutralization, complement
fixation, hemagglutination, or precipitation. The methods are commonly used owing
to a large body of experience in their interpretation, the availability of commercial
reagents, and the relative simplicity of the required instrumentation. Various
technqiues are frequently retained not only for convenience, but a difference in the
conveyed information: e.g., with rubella, maximal titers typically occur at one to
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TABLE 3
Immunodiagnostic Methods
Unlabelled
Aggregation
-electron-microscopic
-platelet
Agglutination
[Direct or Indirect (passive)]
-erythrocytes
(hemagglutination)
-other particles
(latex, bentonite, etc.)
-staphylococcus A
(coagglutination)
Agglutination-inhibition
Complement fixation
(and variants)
Neutralization
Precipitation
Labelled
(type of label)
Electron dense
Electron spin
Enzymatic
Fluorescent
Radioactive
Other
Calorimetric
Chemiluminescent
Potentiometric
two weeks for hemagglutination-inhibition, two to four weeks for complement
fixation, but three to seven months for passive hemagglutination [17].
Neutralization can probably be regarded as the standard test. It is useable
whenever a virus can be cultivated and its results probably relate more closely to the
protective capability of the antibody than the results of any other test. However, it is
laborious, expensive, rather insensitive, and its results are typically unavailable for
several days or weeks. The neutralizing antibody can combine directly with the
receptor, which is responsible for viral attachment to cells, or it can act indirectly. In
the latter case, the antibody reacts with a nearby site where it sterically hinders the
attachment of the virus. Steric hindrance is increased by a subsequent attachment of
a second antibody, directed against the specific antibody, or ofthe early components
ofcomplement (factors C1-C3). Direct damage to the virus occurs with the addition
of the later factors (C5-C9). These features can be used to obtain a manyfold increase
in the sensitivity ofthe neutralization test: e.g., by the addition of a heterologous anti-
immunoglobulin [24] and complement [23]. Neutralizing antibody is frequently more
TABLE 4
Application of Common Immunodiagnostic Methods
Hemagglutination Complement
Neutralization -Inhibition Fixation Immunofluorescence
Adenovirus Adenovirus Adenovirus Adenovirus
Herpesvirus Coronavirus Coxsackievirus Herpesvirus
Lymphocytic Enterovirus LCMV LCMV
choriomeningitis
virus (LCMV)
Picornavirus Myxovirus Myxovirus Myxovirus
Reovirus Poxvirus Poxvirus Poxvirus
Rhabdovirus Reovirus Reovirus Rhabdovirus
Togavirus Rhinovirus Rubella
Togavirus
75specific for the strain or type of the infecting virus than antibody assessed by other
methods. Neutralization can therefore be used not only to assay the antibody but
frequently also to characterize the virus. Modifications of the test have been
employed to obtain quicker results or to derive more information about the reactants
(for example, the number of neutralized sites on avirus). Such modifications include
the plaque reduction assay[25], the use ofan immunofluorescentantibody to identify
infected cells, and kinetic neutralization assay [26].
The complementfixation assay depends on the addition ofa standardized amount
of complement (fresh guinea pig serum) to the viral antigen-antibody mixture [27].
The added complement is consumed and therefore is no longer available to lyse an
indicator system which consists of sheep red cells bearing acomplement-fixing(lytic)
antibody (rabbit anti-sheep red cell hemolysin). Fixation of complement occurs
chiefly with antibody of the IgM and IgG class (but not subclass4), which induce the
classical pathway of complement activation. Other antibody may activate the
alternate pathway. In practice, IgM antibody is sometimes (M. August and A.
Baumgarten, unpublished) detected by the test, but not always, owing to its low
sensitivity and the small amount of IgM found in circulation (compared to the
typically high IgG antibody level).
The assay is widely used but is usually incapable of differentiating between
antibody to different strains or types of a virus. Paradoxically, insensitivity is one of
the virtues of the assay, because the tested antibody becomes detectable rather late in
infection and typically remains so for only a few months. Therefore, antibody
associated with current or recent infection is detected rather than antibody which
persists after an old infection.
The method is subject to considerable inter- and intra-laboratory variability. The
level of antibody also varies considerably between individuals. Assignment of
arbitrary titers for"normal" sera is therefore unreliable, though reproducibility ofthe
assay can be maintained over long periods by the use of aliquots of reagents stored
below -70°C. An acceptable procedure consists of a simultaneous titration of initial
and convalescent sera, the former collected as soon as possible and the latterafteran
interval of two to four weeks.
The basic assay has been modified in various ways which retain the common
feature of utilizing the attachment of complement but assess its effect by different
methods and generally with improved sensitivity.
The modifications include:
-Single radial hemolysis [28,29] and single radial complement fixation [30], in
both of which the complement exercises its lytic function. The former method uses
erythrocytes coated with virus both as the target and the indicator, while the latter
method uses virus in the gel as target but a subsequent layer of hemolysin-sensitized
red cells in agarose as the indicator.
-Immunoadherence hemagglutination [31], in which bound complement is
detected by the adherence of human blood group 0 erythrocytes in the presence of
EDTA to inhibit lysis.
-Assays for the bound factor C3 of complement which is detected by its reaction
with labelled anti-factor C3 antibody (by immunofluorescence [32] or EIA).
Hemagglutination and hemagglutination-inhibition can be used to detect either
antigen (virus) or antibody. Similar assays, which depend on the aggregation of
suitable particles, can be undertaken directly with the virus and the reaction with
antibody be observed by electron microscopy [33]. The assays can use other particles
and the reaction be detected byvarious means; e.g., protein A bearing staphylococcus
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aureus (which binds the antibody initially) can be observed to undergo coagglutina-
tion [34] in the presence of antigen.
In the simplest version, the hemagglutination assay detects the virus by its ability to
agglutinate erythrocytes of an appropriate species of animal. Inhibition of the
agglutination detects the antibody to the viral receptor for the erythrocyte. In reverse
hemagglutination an antibody is used to coat red cells, which are then agglutinated
by the virus, a process which can again be inhibited by antibody in a tested fluid.
Alternatively, a viral antigen is used to coat the erythrocytes which are then
agglutinated by the antibody (passive or indirect hemagglutination). In this case, viral
antigen is assessed by its ability to inhibit the agglutination. The hemagglutination
reaction for antibody while simple in principle and potentially very sensitive,
especially for IgM antibody where its sensitivity can be several thousandfold greater
than for IgG antibody, requires a careful (and often elusive) preparation ofreagents.
The conditions for the preparation of coated red cells include attention to the pH,
type, and concentration of buffer, duration of incubation, the temperature, suitable
concentration (usually high) of viral antigen (which requires at least partial purifica-
tion), and an appropriate preparation of the erythrocye surface. The last may range
from simple washing, through the use of tannic acid (at an appropriate concentra-
tion) to the addition of stabilizing agents (e.g., formaldehyde) and protein coupling
agents [35,36] (gluteraldehyde, chromic chloride, dinitrodifluorobenzene, carbodii-
mide, etc). The hemagglutination reaction, like the neutralization test, can be used in
the kinetic version [37] for improved resolution of antigen.
Precipitation reactions in agarose gels [38] are convenient in that they visibly
display each antigen-antibody system which reaches an adequate concentration, but
they are usually less sensitive than other methods of assay.
Double immunodiffusion (DI) [38,39] has been used chiefly for the detection of
HBs antigen and antibody but also of antibody to CMV, rubella, influenza,
adenovirus, vaccinia, rhinovirus, and measles. It is slow, insensitive, and consumes
large quantities of material, but is useful in comparing complex mixtures of antigen
or antibody.
Counter immunoelectrophoresis (CIE) uses an agarose gel, 0.6-1.0 g/dl, electro-
endosmotic factor 0.12-0.2, in buffer pH 8.2-8.9. In the gel is cut a 3-5 mm diameter
anodal well for antibody and a cathodal well for antigen, 4-6 mm apart. The
reactants are driven toward one another by the application of an electric current,
5-10 V per cm, so that unproductive diffusion is restricted. CIE can be several times
more sensitive than DI, but is still inefficient for many viruses because of their large
size. The disproportion between the migratory speed ofthe antibody and virus can be
reduced by applying the former 10 to 20 minutes before the latter. Obviously, only
electronegatively charged antigens can be detected with conventional antisera. The
principal advantages of the method are its simplicity and speed (results can be
obtained in 30 to 60 minutes). It has been used for the detection of various materials
[40,41], including HBs Ag and antibody, rotavirus, enterovirus, as well as antibody to
CMV, arbovirus, and myxovirus.
Immunoelectrophoresis can be used for the resolution of complex antigenic
mixtures, e.g., measles virus [42], but has had only limited application for viral
immunodiagnosis. Crossed immunoelectrophoresis is a modified method which uses
electrophoresis of the antigen in a plain gel in one dimension, followed by electro-
phoresis into a gel containing antibody in a second dimension, at right angles to the
first. Each antigen produces a rocket-like (A shaped) trail of precipitation in which
the height of the peak reflects the relative concentration of antigen and antibody.
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("rocket" electrophoresis) uses a single antibody and electrophoresis oftheantigen.in
only one direction, but permits quantification of the antigen by reference to a
standard. This method has been used for influenza A [44].
Single radial immunodiffusion (SRID) has been widely applied to the quantifica-
tion of various protein antigens and can achieve sensitivity as high as 0.165 ,ug/ml,
but in mixtures with high protein concentration (e.g., serum), a lower sensitivity
(1-10 Ag/ml) is likely. High sensitivity can be obtained with fixation in 1-4 g/dl
tannic acid, incorporation of 1-2 g/dl polyethylene glycol, MW 4000-6000, in the gel,
overlay with a second antibody (immunofixation), or by the use oflabelled reagents.
However, the method is slow and has limited applicability to whole virus.
Labelled Reagents
Methods which use labelled reagents require only the primary antigen-antibody
reaction, but the product has to be separated from unreacted materials before
measurement.
Direct methods use either labelled antigen, or antibody, to assay an unlabelled
antibody, or antigen, respectively.
Indirect methods use an initial pair of unlabelled reactants, one an antigen, the
other an antibody. A second antibody, which is labelled and reacts with the first
antibody, is then applied. The amount of the bound second antibody is related to the
amount of the bound first antibody which depends, in turn, on the amount of the
antigen in the complex.
Inhibitory reactions depend on the substitution of all, or a portion, of a labelled
material by an unlabelled, but otherwise similar reactant (e.g., an unlabelled antibody
which replaces a labelled antibody, with both antibodies having the same specificity
for antigen). The reaction takes place in sequence (e.g., antigen, unlabelled antibody,
labelled antibody) and the residual amount of bound label is measured.
Competitive assays are similar to the inhibitory ones except that the reactants are
mixed, so that the unlabelled antibody competes with the labelled for the antigen in
the mixture.
The label can be applied either to theantigen or the antibody, provided that it does
not cause a loss of immunoreactivity of the material. The principle is illustrated in
Figs. 1-3.
The assays can be used by successive application ofthe reactants to solid materials
(tissue slices, cultured cells, microtiter plates, test tubes, etc.), by mixing with
microparticulate materials (cells, plastic spheres, etc.) or in fluid mixtures, after a
separation of the bound and residual reactants (e.g., by initial addition of a second
antibody and ammonium sulfate, or staphylococcus with protein A [45] and
centrifugation, or by gel filtration). The type of label which is used for the assay
(Table 3) determines its ultimate sensitivity as well as the required instrumentation.
Immunofluorescence (IF) [46,47] can detect eitherantigen or antibody by means of
an appropriate reactant labelled with a fluorochrome, usually fluorescein, which
gives a yellow-green color, or rhodamine, which gives a red color. Reagents can
contain both fluorochromes [48], e.g., each fluorochrome on a different antibody,
either to characterize distinct antigens (for example, two viruses) or to show that the
antigens occur in close association(e.g., on the same virus), when a combined, orange
fluorescence is seen. The sensitivity of IF is intermediate between that of unlabelled
tests (such as CF), and other methods which use labelled reagents (e.g., EIA or RIA).
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79More sophisticated techniques, such as fluorescence polarization [49], may further
extend the application of the methodology.
Radioimmunoassay (RIA) for protein reactants [50,51] most commonly employs
the 1125 label, which imparts a high sensitivity to the procedure, though others can be
used [52]. The iodine can be introduced with chloramine T or by the gentler N-
succinimidyl 3-(4-hydroxy 5-iodophenyl) propionate, lactoperoxidase, or electrolytic
methods. The labelled reagents become contaminated with degradation products,
however, so that the shelf life varies from several weeks to months. A more stable, but
much less active, label can be used for protein labelling: e.g., C'4 or H3 introduced
with dinitrofluorobenzene [53]. The reagents used for radioimmunoassay can also be
applied to autoradiography with either conventional or electron-microscopic meth-
ods of detection. Another form of RIA, with Cr51, is used for cellular reactants: e.g.,
in the assay of antibody dependent cellular cytotoxicity [54] in viral infection.
Enzymatic immunoassays [55] use the label either in a manner similar to that for
immunofluorescence or radioimmunoassay, as in EIA, or by coupling small antigens
(haptens) to the enzyme and measuring the reduced activity of the enzyme which
occurs when the active site is blocked by an antibody to the hapten.
EIA-type assays, in turn, can provide continuously variable determination of
reactivity, as in conventional, quantitative radioimmunoassay (e.g., for serum
protein), or qualitative assay, or step-wise titration, as with immunofluorescence,
complement fixation, or neutralization. The assays can use labelled antigen, first or
second antibody, or a material which indicates the presence ofantibody: e.g., protein
A of Staphylococcus aureus [56]. The sensitivity of EIA can exceed that of RIA, as
the enzyme may be recycled to produce increasing amounts ofthe measured reaction
product. Extreme sensitivity should be obtained with reaction products which are
themselves labelled and therefore subject to highly sensitive methods of measure-
ment: e.g., substrates which are, or become, radioactive, fluorescent, photoemissive,
or hydrogen donors or acceptors. The last could be measured potentiometrically
(e.g., with enzyme-coated electrodes [57]).
Problems in immunodiagnosis result from biological variability of the tested
individual, the reagents, and the practitioners of the art, as well as errors in procedure
(Table 5). Owing to these variables, "positive" results do not necessarily identify the
pathogenic agent nor do "negative" results exclude it. A positive result may be correct
in a limited sense, yet be misleading because it fails to detect another, responsible
agent: e.g., a virus in multiple infection [58], or an antibody where there is a general
increase in immunoglobulin, or an instance of the "original antigenic sin" [59] (i.e., a
situation where an antibody to an antigenic determinant, to which the subject is
immune, is evoked by another antigenic determinant that is carried by a protein
which is similar to the carrier of the original, immunizing determinant).
Monoclonal Antibody
Conventional antisera contain a mixture of a large amount of non-specific
immunoglobulins and a small quantity of specific antibodies which differ in avidity
and react with various antigenic determinants on the same antigen. Purification of
the immunoglobulin fraction (e.g., by ion-exchange chromatography and gel filtra-
tion) does not markedly affect the heterogeneity of the antibody, except for
restricting the class of immunoglobulin. Affinity chromatography generally results in
a loss of the antibody with highest avidity, but, again, does not otherwise alter the
heterogeneity. Antibody to contaminants, if it is originally present, also remains in
the mixture unless steps are taken to remove it, but such steps often result in a loss
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TABLE 5
Causes of Aberrant Results in Immunoassays
Methodological Biological
Inappropriate method is used Subject is immunologically unresponsive
Procedure is not observed Material is inappropriately collected
(time, source, procedure)
Incorrect or inactive reactants are employed Material lacks specificity
Range of effective concentration of reactants is
exceeded Prior vaccination
Inhibitors are present Multiple infection
Contaminants are present
of specific antibody, which may be extreme. These difficulties can be overcome with
monoclonal antibody.
Monoclonal antibody is produced by a hybridoma [60]. A hybridoma results from
the fusion of a non-secreting mouse plasmacytoma cell and a lymphocyte from a
suitably immunized subject (mouse, human, etc.). The fusion is effected with
polyethylene glycol. Successfully fused cells, selected for their ability to proliferate
and secrete an appropriate antibody, are propagated either in vitro or in mice.
Monoclonal antibody reacts with only a single antigenic determinant and has
uniform avidity. Its ability to recognize an antigen differs from that of conventional
antibody to a complex antigen in that only one, not various, antigenic determinants
are recognized. Therefore, loss or modification of the determinant results in an
inability to recognize an antigen, while an acquisition of the determinant by another
antigen is followed by automatic recognition of the second antigen by the antibody.
The specificity and uniformity of monoclonal antibody should markedly improve
immunodiagnostic accuracy on the one hand [61], while, on the other, it is likely to
focus attention on minute differences between similar antigens [62]. The outcome is
likely to be the use of a battery of several antibodies to characterize type or group
specificity, while the individual antibodies recognize differences between strains. This
may have a considerable impact on the understanding of the pathogenic behavior and
epidemiology of viral strains.
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